BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6207477)

  • 1. Interferon therapy in juvenile laryngeal papillomatosis.
    Lundquist PG; Haglund S; Carlsöö B; Strander H; Lundgren E
    Otolaryngol Head Neck Surg; 1984 Aug; 92(4):386-91. PubMed ID: 6207477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of alpha-leukocyte interferon on laryngeal papillomatosis in children].
    Vacher S; Peytral C; Narcy P
    Presse Med; 1985 Jun; 14(24):1317-8. PubMed ID: 3161020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of the formation of antibodies to interferon in patients with juvenile respiratory papillomatosis on interferon therapy].
    Kol'tsov VD; Chireshkin DG; Onufrieva EK; Nurmukhametov RKh; Malinovskaia VV; Ershov FI
    Vestn Otorinolaringol; 1996; (4):25-7. PubMed ID: 8966873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of long-term leukocyte interferon (alpha IFN) therapy using an individually determined dose schedule in recurrent laryngeal papillomatosis].
    Gerein V; Lodemann E; Bell G; von Ilberg C; Kornhuber B
    Klin Padiatr; 1987; 199(3):224-9. PubMed ID: 3114545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon therapy for laryngeal papillomatosis in adults.
    Bomholt A
    Arch Otolaryngol; 1983 Aug; 109(8):550-2. PubMed ID: 6870649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon therapy in juvenile laryngeal papillomatosis.
    Haglund S; Lundquist PG; Cantell K; Strander H
    Arch Otolaryngol; 1981 Jun; 107(6):327-32. PubMed ID: 6164359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined CO2-laser and alfa recombinant interferon treatment in five children with juvenile laryngeal papillomatosis.
    Mattot M; Ninane J; Hamoir M; Moulin D; Mustin V; Vermylen C; Cornu G
    Acta Clin Belg; 1990; 45(3):158-63. PubMed ID: 2166413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (2'-5')oligo(A) synthetase as a monitor of interferon action in juvenile laryngeal papillomatosis.
    Lodemann E; Kornhuber B; Gerein V; von Il'berg C
    J Interferon Res; 1984; 4(2):283-90. PubMed ID: 6747349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha-interferon treatment of juvenile laryngeal papillomatosis in adults].
    Schuurman AM; van den Broek P
    Ned Tijdschr Geneeskd; 1985 Dec; 129(52):2507-9. PubMed ID: 4088374
    [No Abstract]   [Full Text] [Related]  

  • 10. Further observations on the treatment of recurrent respiratory papillomatosis with interferon: a comparison of sources.
    Sessions RB; Goepfert H; Donovan DT; Dichtel WJ; Gutterman JU
    Ann Otol Rhinol Laryngol; 1983; 92(5 Pt 1):456-61. PubMed ID: 6194728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte interferon in patients with juvenile laryngeal papillomatosis.
    Goepfert H; Sessions RB; Gutterman JU; Cangir A; Dichtel WJ; Sulek M
    Ann Otol Rhinol Laryngol; 1982; 91(4 Pt 1):431-6. PubMed ID: 6180672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial.
    Healy GB; Gelber RD; Trowbridge AL; Grundfast KM; Ruben RJ; Price KN
    N Engl J Med; 1988 Aug; 319(7):401-7. PubMed ID: 3398891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects of alpha-interferon dose variation on laryngeal papillomas.
    Mullooly VM; Abramson AL; Steinberg BM; Horowitz MS
    Laryngoscope; 1988 Dec; 98(12):1324-9. PubMed ID: 3200075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurologic sequelae following interferon therapy of juvenile laryngeal papilloma.
    Vesikari T; Nuutila A; Cantell K
    Acta Paediatr Scand; 1988 Jul; 77(4):619-22. PubMed ID: 2455956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon in the treatment of recurrent laryngeal papillomas].
    Lenarcić-Cepelja I; Krajina Z
    Laryngol Rhinol Otol (Stuttg); 1984 Aug; 63(8):401-2. PubMed ID: 6482620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon joins attack on severe laryngeal papilloma.
    White EC
    JAMA; 1983 Oct; 250(14):1815. PubMed ID: 6620472
    [No Abstract]   [Full Text] [Related]  

  • 17. Side effects of long-term treatment with human leukocyte interferon.
    Ingimarsson S; Cantell K; Strander H
    J Infect Dis; 1979 Oct; 140(4):560-3. PubMed ID: 292735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lightmicroscopical features of interferon-alpha-treated laryngeal papillomatosis in adults.
    Bomholt A; Oestergaard B; Horn T
    Acta Otolaryngol; 1986; 102(1-2):131-5. PubMed ID: 3739686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laryngeal Papillomatosis: A Statistical Analysis of 60 Cases].
    Kurita T; Umeno H; Chitose S; Ueda Y; Mihashi R; Nakashima T
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Mar; 118(3):192-200. PubMed ID: 26349334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of recurrent respiratory papillomatosis with interferon.
    Sessions RB; Dichtel WJ; Goepfert H
    Ear Nose Throat J; 1984 Oct; 63(10):488-93. PubMed ID: 6489206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.